Kontafarma China Holdings Limited (HKG:1312)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
0.0290
0.00 (0.00%)
Apr 29, 2026, 3:55 PM HKT
11.54%
Market Cap 162.07M
Revenue (ttm) 914.71M
Net Income (ttm) -427.85M
Shares Out 5.59B
EPS (ttm) -0.08
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 126,000
Average Volume 1,091,850
Open 0.0270
Previous Close 0.0290
Day's Range 0.0270 - 0.0290
52-Week Range 0.0230 - 0.0480
Beta 0.02
RSI 47.05
Earnings Date Aug 28, 2026

About Kontafarma China Holdings

Kontafarma China Holdings Limited, an investment holding company, manufactures and sells chemical drugs, active pharmaceutical ingredients (API), and API intermediate in Mainland China, Singapore, Taiwan, and internationally. It operates through Pharmaceutical Business and Fitness Business segments. The company offers prescription drugs, including chemical drugs and prescribed traditional Chinese medicines; operates fitness and yoga centers, as well as franchise business; and provides management and consultation services for fitness and health ... [Read more]

Sector Healthcare
Founded 2011
Employees 636
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 1312
Full Company Profile

Financial Performance

In 2025, Kontafarma China Holdings's revenue was 914.71 million, an increase of 1.92% compared to the previous year's 897.52 million. Losses were -427.85 million, 466.4% more than in 2024.

Financial Statements

News

There is no news available yet.